Akoya Biosciences Inc. (AKYA)
1.31
0.04 (3.15%)
At close: Apr 25, 2025, 3:59 PM
1.27
-3.38%
After-hours: Apr 25, 2025, 04:53 PM EDT
Akoya Biosciences Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 12.3M | 12.14M | 34.74M | 17.15M | 15.52M | 15.71M | 14.44M | 14.16M | 13.34M | 12.92M | 10.87M | 10.72M | 9.96M |
| Product Revenue Growth | +1.30% | -65.05% | +102.60% | +10.45% | -1.17% | +8.80% | +1.96% | +6.13% | +3.27% | +18.82% | +1.45% | +7.59% | n/a |
| Service and other Revenue | 6.52M | 6.21M | 16.96M | 6.37M | 5.89M | 5.51M | 4.41M | 3.73M | 3.55M | 3.24M | 3.43M | 4.31M | 2.54M |
| Service and other Revenue Growth | +4.93% | -63.39% | +166.13% | +8.29% | +6.80% | +24.85% | +18.24% | +5.13% | +9.70% | -5.63% | -20.40% | +69.38% | n/a |
| Consumables Revenue | 6.29M | 7M | 12.6M | 5.82M | 5.71M | 4.53M | 4.72M | 4.5M | 4.63M | 4.01M | 7.1M | 6.26M | 6.84M |
| Consumables Revenue Growth | -10.11% | -44.45% | +116.58% | +1.87% | +26.04% | -4.06% | +5.09% | -2.87% | +15.27% | -43.44% | +13.42% | -8.45% | n/a |
| Instruments Revenue | 5.74M | 4.87M | 21.21M | 11.28M | 9.61M | 11.14M | 9.51M | 9.46M | 8.52M | 8.5M | n/a | n/a | n/a |
| Instruments Revenue Growth | +17.83% | -77.05% | +88.12% | +17.37% | -13.74% | +17.06% | +0.54% | +11.06% | +0.28% | n/a | n/a | n/a | n/a |
| Service And Other Revenue | 3.73M | 3.38M | 924K | 52K | 205K | 39K | 200K | 203K | 194K | 409K | n/a | n/a | n/a |
| Service And Other Revenue Growth | +10.14% | +266.13% | +1676.92% | -74.63% | +425.64% | -80.50% | -1.48% | +4.64% | -52.57% | n/a | n/a | n/a | n/a |
| Standalone software products Revenue | 268K | 270K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Standalone software products Revenue Growth | -0.74% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Apac Revenue | 16.55M | 15.06M | 12.53M |
| Apac Revenue Growth | +9.93% | +20.18% | n/a |
| Emea Revenue | 21.8M | 17.75M | 14.36M |
| Emea Revenue Growth | +22.76% | +23.65% | n/a |
| North America Revenue | 58.28M | 42.05M | 28.03M |
| North America Revenue Growth | +38.62% | +50.01% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 14.67M | 19.09M | 19.86M | 18.9M | 19.02M | 22.71M | 21.76M | 20.95M | 19.92M | 20.59M | 18.19M | 19.05M | 13.72M | 10.07M | 8.18M | 6.82M | 5.71M | 5.11M | 6.35M |
| Selling, General, and Administrative Revenue Growth | -23.16% | -3.87% | +5.11% | -0.63% | -16.25% | +4.37% | +3.87% | +5.15% | -3.24% | +13.18% | -4.48% | +38.77% | +36.35% | +23.07% | +20.00% | +19.33% | +11.89% | -19.59% | n/a |
| Research and Development Revenue | 4.47M | 5.29M | 5.55M | 4.67M | 5.17M | 6.27M | 5.77M | 6.43M | 5.47M | 5.6M | 5.71M | 5.56M | 4M | 2.95M | 3.19M | 2.53M | 2.28M | 2.42M | 2.37M |
| Research and Development Revenue Growth | -15.39% | -4.79% | +18.93% | -9.72% | -17.54% | +8.66% | -10.26% | +17.69% | -2.36% | -2.03% | +2.71% | +39.11% | +35.70% | -7.68% | +26.07% | +11.10% | -5.83% | +2.02% | n/a |